Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase
Open accessThe DOI matches its Crossref record.
Abstract
Inhibition of the biosynthesis of proinflammatory cytokines such as tumor necrosis factor and interleukin-1 via p38 has been an approach toward the development of a disease modifying agent for the treatment of chronic inflammation and autoimmune diseases. The development of a new core structure of p38 inhibitors, 3-(4-fluorophenyl)-2-(pyridin-4-yl)-1H-pyrrolo[3,2-b] pyridine, is described. X-ray crystallographic data of the lead bound to the active site of p38 was used to guide the optimization of the series. Specific focus was placed on modulating the physical properties of the core while maintaining potent inhibition of p38. These efforts identified 42c as a potent inhibitor of p38, which also possessed the required physical properties worthy of advanced studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching
Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00384.x · Cited by 675
Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy
Dapper, J. D., Crish, S. D., Pang, I.-H., & Calkins, D. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.001 · Cited by 76
“…catalytic domain and reduce phosphorylation of downstream pathways; it is roughly 50x more potent in binding p38 MAPK and several thousand-fold more selective over other MAP kinases than the more commonly used inhibitor, SB203580 (Peifer et al., 2006; Trejo et al. 2003; Wagner and Laufer, 2006).”
InfluentialMitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis
Paunovic, V., & Harnett, M. M. (2013) · Drugs · doi:10.1007/s40265-013-0014-6 · Cited by 61
Dynamics in the p38α MAP Kinase–SB203580 Complex Observed by Liquid‐State NMR Spectroscopy
Honndorf, V. S., Coudevylle, N., Laufer, S., Becker, S., & Griesinger, C. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705614 · Cited by 22
Metadata
- Authors
- Trejo, A., Arzeno, H., Browner, M., Chanda, S., Cheng, S., Comer, D. D., Dalrymple, S. A., Dunten, P., Lafargue, J., Lovejoy, B., Freire-Moar, J., Lim, J., Mcintosh, J., Miller, J., Papp, E., Reuter, D., Roberts, R., Sanpablo, F., Saunders, J., Song, K., Villasenor, A., Warren, S. D., Welch, M., Weller, P., Whiteley, P. E., Zeng, L., & Goldstein, D. M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-09-19
- Volume
- 46
- Issue
- 22
- Pages
- 4702-4713
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2085146176
- Cited by
- 96
- References
- 0
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase. https://app.cochat.ai/papers/10.1021/jm0301787
- The paper
- Trejo, A., Arzeno, H., Browner, M., Chanda, S., Cheng, S., Comer, D. D., Dalrymple, S. A., Dunten, P., Lafargue, J., Lovejoy, B., Freire-Moar, J., Lim, J., Mcintosh, J., Miller, J., Papp, E., Reuter, D., Roberts, R., Sanpablo, F., Saunders, J., . . . Goldstein, D. M. (2003). Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm0301787
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.